Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume
Open Access
- 21 December 2006
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 578 (1), 309-314
- https://doi.org/10.1113/jphysiol.2006.122689
Abstract
Erythropoietin (Epo) has been suggested to affect plasma volume, and would thereby possess a mechanism apart from erythropoiesis to increase arterial oxygen content. This, and potential underlying mechanisms, were tested in eight healthy subjects receiving 5000 IU recombinant human Epo (rHuEpo) for 15 weeks at a dose frequency aimed to increase and maintain haematocrit at approximately 50%. Red blood cell volume was increased from 2933 +/- 402 ml before rHuEpo treatment to 3210 +/- 356 (P < 0.01), 3117 +/- 554 (P < 0.05), and 3172 +/- 561 ml (P < 0.01) after 5, 11 and 13 weeks, respectively. This was accompanied by a decrease in plasma volume from 3645 +/- 538 ml before rHuEpo treatment to 3267 +/- 333 (P < 0.01), 3119 +/- 499 (P < 0.05), and 3323 +/- 521 ml (P < 0.01) after 5, 11 and 13 weeks, respectively. Concomitantly, plasma renin activity and aldosterone concentration were reduced. This maintained blood volume relatively unchanged, with a slight transient decrease at week 11, such that blood volume was 6578 +/- 839 ml before rHuEpo treatment, and 6477 +/- 573 (NS), 6236 +/- 908 (P < 0.05), and 6495 +/- 935 ml (NS), after 5, 11 and 13 weeks of treatment. We conclude that Epo treatment in healthy humans induces an elevation in haemoglobin concentration by two mechanisms: (i) an increase in red cell volume; and (ii) a decrease in plasma volume, which is probably mediated by a downregulation of the rennin-angiotensin-aldosterone axis. Since the relative contribution of plasma volume changes to the increments in arterial oxygen content was between 37.9 and 53.9% during the study period, this mechanism seems as important for increasing arterial oxygen content as the well-known erythropoietic effect of Epo.Keywords
This publication has 19 references indexed in Scilit:
- Effects of ATP-induced leg vasodilation on V̇o2 peak and leg O2 extraction during maximal exercise in humansAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Norepinephrine-induced vasoconstriction results in decreased blood volume in dialysis patientsNephrology Dialysis Transplantation, 2006
- Pulmonary gas exchange at maximal exercise in Danish lowlanders during 8 wk of acclimatization to 4,100 m and in high-altitude Aymara nativesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Why is V˙o 2 max after altitude acclimatization still reduced despite normalization of arterial O2 content?American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2003
- Losartan may modulate erythropoietin productionJournal of the Renin-Angiotensin-Aldosterone System, 2001
- Dose-dependent effect of angiotensin II on human erythropoietin productionPflügers Archiv - European Journal of Physiology, 2000
- Effect of erythropoietin administration on mammal aerobic powerScandinavian Journal of Medicine & Science in Sports, 1991
- Direct vasopressor effect of recombinant human erythropoietin on renal resistance vesselsKidney International, 1991
- Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy menJournal of Internal Medicine, 1991
- Blood volume and haemoglobin concentration at altitudes above 18,000 ft. (5500 m)The Journal of Physiology, 1964